| Dr Larry Sprung, MD | |
|
5900 N Port Washington Rd, Suite 230, Glendale, WI 53217 | |
| (414) 962-4048 | |
| (414) 962-4052 |
| Full Name | Dr Larry Sprung |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 38 Years |
| Location | 5900 N Port Washington Rd, Glendale, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447278940 | NPI | - | NPPES |
| 31610100 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 28595020 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Behavioral Clinics Sc | 7517937964 | 23 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have conducted the first study to detect the presence of a protein in human milk that may explain the association between breastfeeding and reduced risk of obesity later in life.
Accreditation Canada's 2010 national report on health care in Canada explores the connection between quality of worklife and patient safety in health organizations. The report also examines the relationship between health care staff perceptions of work climate and patient safety culture in their own organizations, and how those perceptions are useful in identifying patient safety issues.
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
The Senate Finance Committee on Thursday defeated an amendment that sought to squeeze more money out of pharmaceutical companies to help pay for the costs of changing the health care system. The panel's vote was a victory for President Obama and Finance Chairman Max Baucus.
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
› Verified 3 days ago
| Entity Name | County Of Milwaukee |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942362066 PECOS PAC ID: 0446162887 Enrollment ID: O20031104000139 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have conducted the first study to detect the presence of a protein in human milk that may explain the association between breastfeeding and reduced risk of obesity later in life.
Accreditation Canada's 2010 national report on health care in Canada explores the connection between quality of worklife and patient safety in health organizations. The report also examines the relationship between health care staff perceptions of work climate and patient safety culture in their own organizations, and how those perceptions are useful in identifying patient safety issues.
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
The Senate Finance Committee on Thursday defeated an amendment that sought to squeeze more money out of pharmaceutical companies to help pay for the costs of changing the health care system. The panel's vote was a victory for President Obama and Finance Chairman Max Baucus.
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
› Verified 3 days ago
| Entity Name | Aurora Psychiatric Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881627438 PECOS PAC ID: 5799682076 Enrollment ID: O20031215000930 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have conducted the first study to detect the presence of a protein in human milk that may explain the association between breastfeeding and reduced risk of obesity later in life.
Accreditation Canada's 2010 national report on health care in Canada explores the connection between quality of worklife and patient safety in health organizations. The report also examines the relationship between health care staff perceptions of work climate and patient safety culture in their own organizations, and how those perceptions are useful in identifying patient safety issues.
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
The Senate Finance Committee on Thursday defeated an amendment that sought to squeeze more money out of pharmaceutical companies to help pay for the costs of changing the health care system. The panel's vote was a victory for President Obama and Finance Chairman Max Baucus.
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
› Verified 3 days ago
| Entity Name | American Behavioral Clinics Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144313859 PECOS PAC ID: 7517937964 Enrollment ID: O20040731000040 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have conducted the first study to detect the presence of a protein in human milk that may explain the association between breastfeeding and reduced risk of obesity later in life.
Accreditation Canada's 2010 national report on health care in Canada explores the connection between quality of worklife and patient safety in health organizations. The report also examines the relationship between health care staff perceptions of work climate and patient safety culture in their own organizations, and how those perceptions are useful in identifying patient safety issues.
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
The Senate Finance Committee on Thursday defeated an amendment that sought to squeeze more money out of pharmaceutical companies to help pay for the costs of changing the health care system. The panel's vote was a victory for President Obama and Finance Chairman Max Baucus.
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Larry Sprung, MD 5900 N Port Washington Rd, Suite 230, Glendale, WI 53217 Ph: (414) 962-4048 | Dr Larry Sprung, MD 5900 N Port Washington Rd, Suite 230, Glendale, WI 53217 Ph: (414) 962-4048 |
News Archive
Researchers at Cincinnati Children's Hospital Medical Center have conducted the first study to detect the presence of a protein in human milk that may explain the association between breastfeeding and reduced risk of obesity later in life.
Accreditation Canada's 2010 national report on health care in Canada explores the connection between quality of worklife and patient safety in health organizations. The report also examines the relationship between health care staff perceptions of work climate and patient safety culture in their own organizations, and how those perceptions are useful in identifying patient safety issues.
Anavex Life Sciences Corp. announced today that ANAVEX 2-73 has been named 2010's "most promising trial drug" by the editorial staff at Alzheimer's Weekly. The publication selected the ANAVEX 2-73 trial from a field of over 100 trials that treat dementias such as Alzheimer's and following the review of more than 10,000 articles.
The Senate Finance Committee on Thursday defeated an amendment that sought to squeeze more money out of pharmaceutical companies to help pay for the costs of changing the health care system. The panel's vote was a victory for President Obama and Finance Chairman Max Baucus.
SRU Biosystems today announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND® SCANNER for primary and stem cell applications. The BIND SCANNER is a first-of-its-kind, plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.
› Verified 3 days ago
Virginia M. Linabury, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 250 W Coventry Ct, Suite 209, Glendale, WI 53217 Phone: 414-351-7726 Fax: 414-351-7721 | |
Dr. Matthew David Krasucki, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1720 W Florist Ave Unit 203, Glendale, WI 53209 Phone: 414-649-7909 | |
Ilva E Van Valkenburgh, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 305 W Silver Spring Dr, Glendale, WI 53217 Phone: 414-885-0080 Fax: 414-885-0081 | |
Dr. David W Schulz, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5900 N Port Washington Rd, Suite 230, Glendale, WI 53217 Phone: 414-962-4048 Fax: 414-962-4052 |